Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2024
Pharma News, 2024
BeiGene opens biologics facility in New Jersey, US
BeiGene has announced the opening of its new US biologics manufacturing and clinical research and development (R&D) facility at Hopewell, New Jersey. Situated at the Princeton West Innovation ...
Preclinical model offers new insights into Parkinson's disease process
A new preclinical model offers a unique platform for studying the Parkinson's disease process and suggests a relatively easy method for detecting the disease in people, according to a new study le...
DSP-5336 Receives Fast Track Designation From the FDA for Acute Myeloid Leukemia Subtype
Fast track designation has been granted by the FDA to the investigational menin and mixed-lineage leukemia (MLL) inhibitor DSP-5336 as a potential treatment for relapsed/refractory acute myelo...
Samsung Bioepis’ Epyscyi gets FDA approval as biosimilar to Soliris
South Korean pharma firm Samsung Bioepis has secured approval from the US Food and Drug Administration (FDA) for Epyscyi (eculizumab-aagh) as a biosimilar to Alexion Pharmaceuticals’...
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
New findings highlight potential advantages of MIRA's novel oral ketamine analog for treating neurological and neuropsychiatricdisorders
Israeli Heart Failure Treatment Secures FDA Breakthrough Status
An Israeli treatment for congestive heart failure has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA).
Zuranolone Offers a Much-Needed Option For Postpartum Depression
Postpartum depression (PPD) is largely underdiagnosed and therefore, undertreated.
Preclinical study shows promise of systemic targeted therapy in a rare form of cancer
Pseudomyxoma peritonei is a rare and poorly understood cancer, characterized by the progressive accumulation of mucin in the abdominal cavity.
Seventh patient ‘cured’ of HIV among highlights at AIDS 2024
The 25th International AIDS Conference will be held between 22 and 26 July in Munich, Germany.
Boehringer Ingelheim offers Humira biosimilar at 92% discount
Boehringer Ingelheim will sell an unbranded version AbbVie’s reference drug at a 92% discount to gain traction in the Humira (adalimumab) biosimilar market.
FDA establishes rare disease innovation hub to accelerate treatment development
The US Food and Drug Administration (FDA) has announced plans to establish a new innovative hub aimed at improving treatment options for rare disease patients.
US FDA grants priority review for Pierre Fabre’s EBV+ PTLD
The US Food and Drug Administration (FDA) has accepted the biologics licence application (BLA) and granted priority review for Pierre Fabre Pharmaceuticals’ Tabelecleucel (Tab-ce...
13
14
15
16
17
18
19
20
21
